Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
625日前
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
891日前
Fed Leaves Interest Rates Unchanged, Warns Of Higher Unemployment, Inflation.
The Federal Reserve on Wednesday announced its widely expected decision to leave interest rates unchanged, highlighting increased uncertainty about the economic outlook. The Fed said it decided to leave the target for the federal funds rate at 4.25 to 4.50 percent for the third straight meeting.
RTTNews
|
2時38分前
Swiss Franc Rises Against Majors
The Swiss franc climbed against its major counterparts in the New York session on Wednesday.
RTTNews
|
3時23分前
Swiss Market Ends Nearly 1% Down
Swiss stocks opened on a weak note on Wednesday and languished in negative territory right through the day's session as investors stayed cautious ahead of the Federal Reserve and the Bank of England's monetary policy announcements, due later in the day, and on Thursday, respectively.
RTTNews
|
3時34分前
Major European Markets Close On Weak Note After Cautious Session
The major European markets closed weak on Wednesday as investors reacted to earnings announcements, and awaited the monetary policy announcement from the Federal Reserve later in the day. The Bank of England's policy announcement is due on Thursday.
Upbeat economic data from Germany, and optimism surrounding upcoming U.S.-China trade talks helped limit markets' downside.
RTTNews
|
3時49分前
Canadian Stocks Up Firmly In Positive Territory
The Canadian market is up firmly in positive territory a little past noon on Wednesday, lifted by gains in utilities, technology, consumer and financials sectors.
The market undertone is positive amid slightly easing tensions about tariffs ahead of U.S.-China meeting this week, and expectations that the Federal Reserve will hold interest rates unchanged.
RTTNews
|
4時34分前
German Factory Orders Rebound Ahead Of U.S. Tariffs
Germany's factory orders grew more than expected in March as U.S. manufacturers front-loaded their orders to avoid higher tariffs, official data revealed Wednesday. Factory orders advanced 3.6 percent month-on-month in March after remaining flat in February, Destatis reported. Orders are forecast to grow 1.4 percent.
RTTNews
|
7時22分前
